BNP-7787 (BioNumerik/Baxter Oncology/Grelan).

BNP-7787 (BioNumerik/Baxter Oncology/Grelan).

IDrugs : the investigational drugs journal (2004-01-20)

R Todd Reilly

摘要

BioNumerik Pharmacology Inc, Baxter Oncology GmbH (formerly ASTA Medica AG) and Grelan Pharmaceutical Co Ltd are developing BNP-7787 for the potential reduction of toxicity associated with cisplatin and carboplatin treatment in cancer patients.

材料

货号

品牌

产品描述

Y0000317

美司钠杂质D, European Pharmacopoeia (EP) Reference Standard